Medicrea Reports First Half 2019 Sales

The Medicrea Group (Euronext Growth Paris - FR0004178572 - ALMED; OTCQX Best Market – MRNTF), pioneering the digital transformation of spinal surgery through artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes sales for the first half of 2019.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190709005802/en/

(Photo: Business Wire)

(€ millions)	H1 2018	H1 2019	Variation	Variation at Constant Exchange Rate
USA Rest of the world	7.6 7.0	8.7 7.4	+15% +6%	+7% +6%
Total Sales – Comparable basis Discontinued activities Total Sales	14.6 2.3 16.9	16.1 - 16.1	+10% - (5)%	+6% - (9)%

Sales for the first half of 2019 amounted to 16.1 million euros, up 10% (+6% at constant exchange rates) compared to 2018 on a pro-forma basis. In the United States, the Group's most significant market, sales growth continued with an increase of 15% compared to 6% for the rest of the world (respectively + 7% and + 6% at constant exchange rates). As previously mentioned, Medicrea discontinued non-strategic activities on July 1^st, 2018, which represented 2.3 million euros of sales in the first half of 2018, showing a total decrease in sales of 5% over the period. These activities will no longer impact the period-over-period comparisons effective the second half of 2019.